Publication | Open Access
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
377
Citations
43
References
2015
Year
Our data demonstrate the potential of ErbB2-specific NK-92/5.28.z cells for adoptive immunotherapy of glioblastoma, justifying evaluation of this approach for the treatment of ErbB2-positive GBM in clinical studies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1